Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 16.281\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a COc1cc(CC(=O)OCC(=O)Nc2ccc(Cl)c(S(=O)(=O)N(C)C)c2)cc(OC)c1OC
b CC(C)CN(C(=O)CCCSc1nc2ccccc2[nH]1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
c O=C(NCc1cccs1)Nc1ccc2c(c1)OCO2
d CCC(=O)Nc1ccccc1C(=O)N1CCOCC1
e COc1ccc2oc3cc(C)[n+]([O-])c(-c4ccc(C)cc4)c3c2c1
Answer: d. CCC(=O)Nc1ccccc1C(=O)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)Nc1ccccc1C(=O)N1CCOCC1
CCC(=O)Nc1ccccc1C(=O)N1CCOCC1
N-[2-(morpholine-4-carbonyl)phenyl]propanamide